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Hyperbaric oxygen therapy (HBOT), referring to the medical use of oxygen at a level higher than atmospheric
pressure, exerts neuroprotective effects after ischemic stroke via various mechanisms. It has been demonstrated that
HBOT modulates the synthesis and degradation of hormones. Leptin, an adipose derived hormone, has been found
to confer neuroprotection following experimental stroke. However, it is not known whether HBOT alters leptin
concentrations after permanent middle cerebral artery occlusion (pMCAo) in the rat. In this present study, we aimed
to investigate the effect of HBOT on the serum concentration of leptin in rats subjected to pMCAo. HBOT was
initiated 48 hrs after experimental pMCAo, at 2.5 atmospheres absolutes with 100% oxygen, 1 hr a day for 10
consecutive days. Body weight, neurobehavioral deficits and infarct size were evaluated. Blood was collected on
day 1 and day 16 following HBOT. Serum leptin concentrations were measured with ELISA. Delayed HBOT reduced
infarct size and improved neurobehavioral scores. Decreased serum levels of leptin were found in treated and
untreated pMCAo animals, compared to the sham group on day 1 (P > 0.05) and day 16 (P < 0.05). However, no
statistical significance was found between HBOT and the air group. We concluded that the neuroprotective effects
of delayed HBOT in pMCAo rats were unlikely to be exerted through changes in the serum concentration of leptin.
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Hyperbaric oxygen therapy (HBOT) refers to the medical
use of oxygen at levels higher than atmospheric pressure.
The potential applications of HBOT following ischemic
stroke have been investigated in various animal models
and clinical trials [1-5]. Previous studies utilizing experi-
mental models of ischemic stroke demonstrated that
HBOT improved neurological functions [3], reduced in-
farct size [3,4], decreased hemorrhagic transformation [5],
and promoted neurogenesis [6-9]. It has also been sug-
gested that these effects are achieved through a variety of
mechanisms, including reduction of oxidative and meta-
bolic stress, amelioration of brain edema, suppression of
inflammation and apoptosis, as well as stabilization of the
blood brain barrier, by activation of cellular transcription* Correspondence: johnzhang3910@yahoo.com
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reproduction in any medium, provided the orfactors [10]. A major effect of HBOT is the elevation of
oxygen partial pressure within the blood and therefore the
restoration of oxygen supply to the penumbra after ische-
mic stroke [11].
Recent evidence revealed that HBOT modulates the
synthesis and degradation of several hormones. Edstrom
and his colleagues investigated the effect of HBOT on
endocrine organs and found that hyperbaric oxygen
evoked adrenal hypertrophy, reduced thymus weight but
increased thyroid weight [12]. Animal experiments fur-
ther demonstrated that serum levels of adrenal epineph-
rine and norepinephrine increased in spontaneously
hypertensive rats that received HBOT (2 ATA, 90 min)
[13]. The serum concentration of cortisol, as well as the
concentration of glucocorticoid receptors in the rat’s
lung were reduced following HBOT (3 ATA, 5 hrs) [14].
In clinical studies, HBOT (2.0 ATA, 10 days) increased
serum levels of estrogen and estrogen receptors in infertile
patients [15], and decreased erythropoietin (EPO) concen-
trations in healthy subjects (2.5 ATA, 90 min) [16]. HBOT. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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trol and reduced insulin requirements in patients with type
2 diabetes mellitus (T2DM) after stem cell transplantation
[17]. However, short-term HBOT (2.5 ATA, 90 min X 3
days) did not alter levels of circulating insulin, insulin-like
growth factor (IGF), leptin, interleukin-8 (IL-8) or nitric
oxide (NO) in patients with T2DM [18]. Furthermore, sin-
gle HBOT (2.5 ATA, 1 hr) failed to induce a generalized
hormonal stress reaction in 8 divers, who showed normal
serum concentrations of epinephrine, norepinephrine,
antidiuretic hormone (ADH), atrial natriuretic peptide
(ANP) and renin after the HBOT session [19]. In summary,
while it has been suggested that HBOT interrelates with
endogenous hormone pathways, long-term HBOT, rather
than single or short-term based therapies, affected the hor-
mone balance to a greater extend. So far, there is no re-
search related to hormone profiles induced by HBOT in
ischemia patients or animal models. Thus, it is not clear
whether HBOT can ameliorate ischemic brain injury by
modulating the serum levels of specific hormones.
Among all hormones modulated with HBOT, leptin is a
promising candidate for the treatment of ischemic stroke
[20]. Leptin, a 16 kDa peptide produced and released by
adipocytes, acts via its receptors in the hypothalamus to
decrease appetite and increase energy expenditure [21,22].
The secretion of leptin from adipocytes is regulated by
multiple factors, including body weight, food intake, insu-
lin and hypoxia [23]. Exogenous administration of leptin,
attenuated neuronal hypoxic injury in both in vivo [24,25]
and in vitro [20,26] studies. Endogenous leptin expression
as well as mRNA levels were found increased in the peri-
infarct brain tissue up to 24 hrs after permanent middle
cerebral artery occlusion (pMCAo) in mice [27]. In
oxygen-breathing mice, serum leptin was increased six to
seven fold by hyperoxia and leptin mRNA was elevated
within the adipose tissue [28]. To date, no studies have in-
vestigated the relationship between HBOT and endogen-
ous leptin in ischemic stroke models. In this present
study, we hypothesized that multiple and long term
HBOT can exert neuroprotection by increasing the serum
level of leptin in pMCAo rats.
Materials and Methods
Animals
All experiments were approved by the Institutional Animal
Care and Use Committee (IACUC) of Loma Linda University.
Seventy-two Sprague–Dawley male rats (Harlan, Indianapolis,
Ind) weighing 240 to 270 g were randomly divided into
the following groups: sham-operated + air (n = 20), air
(pMCAo + air) (n = 28) and HBOT (pMCAo + 2.5 ATA
HBOT) (n = 24). Animals were fed with a standard labora-
tory diet, and were housed in a temperature-controlled
room (24°C), illuminated for 12 hrs daily (lights on from 5
AM to 5 PM).Surgery
Rats were anesthetized via intraperitoneal injection of
ketamine (100 mg/kg) and xylazine (8 mg/kg). The rectal
temperature was monitored and kept at 37.0 ± 0.5°C, by
using a feedback-regulated heating system during sur-
gery. Permanent focal ischemia was induced by occlud-
ing the right middle cerebral artery (MCA) via the
intraluminal technique [29]. Briefly, a 4–0 nylon mono-
filament suture with a slightly enlarged round tip was
inserted into the stump of the external carotid artery
(ECA) and advanced into the lumen of the internal carotid
artery (ICA) until it reached and occluded the MCA. The
distance from bifurcation of the common carotid artery
(CCA) to the tip of the suture averages 18–20 mm. Sham
operated animals were subjected to the same surgery pro-
cedure, except that no suture was inserted.
HBOT paradigm
HBOT was initiated 48 hrs after the pMCAo, at 2.5 atmo-
spheres absolutes with 100% oxygen, 1 hr a day for 10
consecutive days (Figure 1). Rats were pressurized in a re-
search hyperbaric chamber (1300B, Sechrist) with an oxy-
gen flow of 22 L/min. Compression and decompression
was maintained at a rate of 5 psi (pounds per square
inch)/min. For sham and vehicle groups, normobaric air
was used.
Neurobehavioral Testing
At 4 weeks after pMCAo, rotarod and open field tests
were performed to assess motor coordination, motor
learning and locomotor activity respectively. The rotarod
test consists of a rotating horizontal cylinder divided
into 9.5 cm-wide lanes. When animals were placed onto
it, they must move forward continuously to avoid falling
off. Latency to fall off is recorded by a photobeam circuit
[30]. In the open field tests, animals were observed for
30 min in opaque open-topped plastic boxes (49 cm X
35.5 cm X 44.5 cm) and recorded by an overhead cam-
era. The animals' movements were analyzed by the com-
puterized tracking system [30].
Body weight
All rats were weighed before surgery and on days 1, 7, 14
and 28 after surgery. Body weight changes were expressed
as the percentage of the baseline value obtained prior to
surgery.
Nissl staining
On day 28 after surgery, rats were transcardially per-
fused with 200 mL of ice cold phosphate-buffered saline
(PBS), followed by 300 mL of phosphate-buffered 10%
formalin. Brains were postfixed and cryoprotected as de-
scribed [31]. Detection of infarct tissue was performed
on 10 consecutive sections cut into 10 μm-thick coronal
Figure 1 Experimental design.
Figure 2 Effects of HBOT on Rotarod test. *P < 0.05 vs air group.
The animal number was 20, 20 and 22, respectively in the sham, air
and HBOT group.
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For Nissl staining, the sections were dried, rehydrated and
immersed in 0.5% cresyl violet for 2 minutes [21]. After
washing in water, sections were dehydrated in graded alco-
hols, cleared in xylene and cover-slipped with Permount
(Thermo Fisher Scientific). Infarction volume was quanti-
tatively analyzed by sum of the infarction area in all brain
slices,multiplied by thickness of each slice.
Serum leptin measurement
Serum leptin concentration in normal rats exhibits a diur-
nal pattern, peaking at 2 hrs after dark [22]. In view of this,
blood was collected between 7:00 PM to 9:00 PM at 1 and
16 days after the last HBOT session. Serum was separated
by centrifugation at 3,000 g for 10 minutes at 4°C and
stored at −20°C. Serum leptin concentrations were mea-
sured with a rat leptin enzyme-linked immunosorbent
assay (ELISA) kit (Millipore, MA, USA).
Statistical analysis
Results were expressed as mean ± SEM. Intergroup differ-
ences for were analyzed by ANOVA, using SigmaStat
(Systat Software, CA, USA). A P value of 0.05 or less was
considered significant.
Results
Mortality rate, body weight, neurobehavioral data and
infarct volume
The mortality at day 28 was 0% (0/20) in the sham
group, 28.6% (8/28) in the air group (pMCAo + air) and
8.3% (2/24) in the HBOT group. The mortality in the
HBOT group tended to be lower than that of the air
group (P > 0.05).
Rotarod test results of motor coordination and motor
learning were significantly improved on 10 RPM com-
pared with the air group (P < 0.05) (Figure 2). Locomotor
activity was evaluated by open field test, expressed as total
distance moved (Figure 3A) and as total duration of mov-
ing (Figure 3B). However, no statistical significance was
noted between the air and HBOT groups (P > 0.05).Body weight was recorded on day 1, 7, 14 and 28
(Figure 4) and was expressed as percent difference of pre-
operative weight. There was no statistically significant dif-
ferences in the baseline weight between the groups. There
was no statistically significant differences in weight be-
tween the HBOT group as compared to air group at each
time point (P > 0.05).
Infarct volume was reduced in the HBOT group com-
pared with the air group on day 28 after surgery (P < 0.05)
(Figure 5).
Leptin levels
Although leptin level tended to be lower in the pMCAo
groups compared with sham operated animals, there was
no statistically significant difference between these two
groups (pMCAo + air vs. pMCAo +HBOT) 1 day after the
last session of HBOT. On day 16 after the last session of
HBOT, serum level of leptin was found further reduced in
the pMCAo groups compared with the sham group
(Figure 6) (P < 0.05). The leptin concentration in the
Figure 3 Effects of HBOT on open field test. There was no difference between air and HBOT group in the total distance moved (cm)
(Figure 3A) and total duration of moving (%) (Figure 3B). The animal number was 20, 20 and 22, respectively in the sham, air and HBOT group.
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pared with that in the serum of air-treated rats (P > 0.05).Discussion
In this present study, we applied delayed HBOT to
pMCAo rats in order to explore whether the treatment
exerts neuroprotection by modulating the serum con-
centration of leptin. We found that daily HBOT, initiated
48 hrs after pMCAo, reduced infarct size and improved
neurological scores. Both air treated and HBOT pMCAo
groups showed a tendency toward decreased leptin levels
compared to sham animals on day 1 (P > 0.05) and a sig-
nificant decrease leptin level on day 16 (P < 0.05), mea-
sured after the last session of HBOT. The leptin level inFigure 4 Weight changes on day 1, 7, 14 and 28. Body weight of
rats expressed as percent difference of preoperative weight. There
were no statistically significant differences in the baseline weight
between the groups. There were no statistically significant
differences in weight between the HBOT group as compared to air
group at each time point. The animal number was 20, 20 and 22,
respectively in the sham, air and HBOT group.the HBOT group tended to be higher than the air group
without any noted statistical significance.
PMCAo model, compared to the transient MCAo model,
was selected for the present study as it represents the nat-
ural evolution of focal ischemia in clinical situations with-
out spontaneous recanalization. While both models are
well reproducible, pMCAo model was less variable in terms
of lesion size [32]. Also, it is difficult to start the HBOT im-
mediately from the very acute stage in ischemic stroke pa-
tients, for the reason of recombinant tissue plasminogen
activator (rt-PA) administration, intensive care monitoring
and generally unavailability of spacious HBO chamber.
Therefore, the latest initiation of HBOT was applied 24 hrs
after the transient MCAo [3]. As demonstrated already in
our previous study, delayed and continuous HBOT
(starting 48 hrs after ischemia) effectively reduced infarct
size and improved neurobehavioral scores.
It has been known that serum leptin concentration in
normal rats exhibits a diurnal pattern and peaking at 2Figure 5 Changes of infarct volume at 28 days after HBOT. The
infarct volume was calculated in mm3 of infarcted tissue per
ipsilateral hemisphere. *P < 0.05 vs air group. The animal number
was 20, 20 and 22, respectively in the sham, air and HBOT group.
Figure 6 Changes of leptin concentration. Leptin level in the
serum of treated animals showed no statistically significant
difference compared with that in the serum of air rats both on day
1 and day 16 after last session of HBOT. *P < 0.05 vs sham group.
The animal number was 20, 20 and 22, respectively in the sham, air
and HBOT group.
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AM to 5:00 PM in our study. As a result, serum was
uniformly collected from 7PM to 9PM. Since HBOT ses-
sions lasted for 10 days, 2 time points were chosen for
blood collection: one day after the last session of HBOT
for the acute effect of HBOT on level of leptin and 16
days after the last session of HBOT for the observation
of chronic effects.
In this study, no significant differences of body weight
between air group and HBOT group were found at each
time point. Animals subjected to pMCAo showed sig-
nificantly more weight loss compared with the sham
group. That partly explained why 1 day after the last ses-
sion of HBOT, there was a decrease of leptin level in
both air and HBOT group. However, more than 2 weeks
later, when body weight recovered to above the pre-
operative level, there was a further decrease of leptin
level in both groups, suggesting the change of leptin
level was irrelevant to that of body weight. Although the
leptin level in HBOT group tended to be higher than
that of the air group, the difference was not statistically
significant. Clinical investigations revealed that acute
stroke patients have increased serum levels of leptin [33]. It
has been reported that increased level of leptin is associated
with abdominal obesity [34], higher risk of ischemic stroke
[33] and post-stroke depression [35]. Exogenous adminis-
tration of leptin, exerted neuroprotection against ischemia
brain injury both in vivo [24,25] and in vitro [20,26].
Barazzone-Argiroffo and collegues reported that serum lep-
tin was increased six to seven fold in oxygen-breathing
hyperoxia mice [28]. It is postulated that acute hypoxia-
induced increase in leptin level produces neuroprotection
and HBOT may further increase the leptin level thereforeenhance neuroprotection. However, we didn’t observe any
leptin increase either 1 day or 16 days after last session of
HBOT. Possible explanations may include: 1) leptin level
increased within the first few days of ischemia then felled at
day 12; 2) the HBOT-induced increase in the level of leptin
was absorbed by the ischemia insult to cause a neuro-
protective effect of reducing the infarct size and improving
the neurobehavioral scores; 3) HBOT sessions were not
long enough to cause further increase of leptin, because on
day 28, there was slightly higher level of leptin in HBOT
group, compared with the air group; 4) serum level of leptin
is not sensitive enough to be detected as compared to the
brain tissue leptin expression and mRNA level.
To further evaluate whether HBOT modulates the
level of leptin, more groups at different time points
should be considered: 1) HBOT sessions further ex-
tended; and 2) HBOT initiated immediately after ische-
mia. Aside from the serum level of leptin, gastric and
hypothalamic leptin level might be tested at the same
time. In addition, leptin mRNA and leptin receptors are
important index modulated by HBOT.
Conclusions
Delayed HBOT produced neuroprotective effects on
pMCAo rats. Serum leptin levels were decreased after
pMCAo in rats and remained unaffected by delayed
HBOT. The decreased level of serum leptin in HBOT
group was possibly because of counteracting effect of is-
chemia insult against HBOT. Noticeably though, the lep-
tin level in the HBOT group showed a tendency to
increase, compared to air group. To further elucidate
whether HBOT exerts the neuroprotection through
modulation of leptin expression, leptin level, mRNA and
receptors need to be examined at various additional time
points, as outlined above.
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